ProShares Short S&P500 (NYSEARCA:SH) Sets New 52-Week Low at $25.86

Share on StockTwits

ProShares Short S&P500 (NYSEARCA:SH)’s stock price reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $25.86 and last traded at $25.88, with a volume of 248298 shares trading hands. The stock had previously closed at $26.02.

The firm has a 50 day simple moving average of $26.68 and a 200-day simple moving average of $27.12.

Several institutional investors have recently bought and sold shares of the company. Advisory Services Network LLC acquired a new stake in ProShares Short S&P500 during the first quarter worth approximately $33,000. Institutional & Family Asset Management LLC acquired a new stake in ProShares Short S&P500 during the second quarter worth approximately $37,000. Parallel Advisors LLC acquired a new stake in ProShares Short S&P500 during the first quarter worth approximately $41,000. Steward Partners Investment Advisory LLC acquired a new stake in ProShares Short S&P500 during the second quarter worth approximately $46,000. Finally, Capital Directions Investment Advisors LLC acquired a new stake in ProShares Short S&P500 during the first quarter worth approximately $108,000.

ProShares Short S&P500 Company Profile (NYSEARCA:SH)

ProShares Short S&P500 (the Fund) seeks daily investment results that correspond to the inverse (opposite) of the daily performance of the S&P 500 Index (the Index). The S&P 500 Index is a measure of large-cap United States stock market performance. It is a capitalization weighted index of 500 United States operating companies and selected real estate investment trusts.

Read More: What are no-load funds?

Receive News & Ratings for ProShares Short S&P500 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ProShares Short S&P500 and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Encompass Health  Research Coverage Started at Deutsche Bank
Encompass Health Research Coverage Started at Deutsche Bank
Critical Contrast: PlusTherapeuticsInc   .  vs. Stryker
Critical Contrast: PlusTherapeuticsInc . vs. Stryker
Contrasting Sito Mobile  and Invictus Financial
Contrasting Sito Mobile and Invictus Financial
Pinnacle Financial Partners  Rating Reiterated by Stephens
Pinnacle Financial Partners Rating Reiterated by Stephens
Goldman Sachs Group Trims New Relic  Target Price to $52.00
Goldman Sachs Group Trims New Relic Target Price to $52.00
L3Harris  PT Raised to $250.00 at Jefferies Financial Group
L3Harris PT Raised to $250.00 at Jefferies Financial Group


 
© 2006-2019 Zolmax.